药物涂层球囊治疗股总动脉病变的有效性及安全性  

Efficacy and safety of drug-coated balloon for treatment of common femoral artery lesions

作　　者：姚子平 杨敏[1] 宋莉[1] 邹英华[1] YAO Ziping;YANG Min;SONG Li;ZOU Yinghua(Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing 100034, China)

机构地区：[1]北京大学第一医院介入血管外科,北京100034

出　　处：《中国介入影像与治疗学》2020年第6期333-337,共5页Chinese Journal of Interventional Imaging and Therapy

摘　　要：目的观察药物涂层球囊(DCB)治疗股总动脉病变的有效性和安全性。方法回顾性分析11例接受DCB治疗的股总动脉病变患者。结果11例中,股总动脉闭塞7例,重度狭窄4例;9例为原发病变引发狭窄,2例为支架内再狭窄;股总动脉病变累及股浅动脉5例,单纯股总动脉病变6例。5例接受减容联合药物球囊、6例接受单纯药物球囊治疗,技术成功率100%。术后均未出现相关并发症,术后30天内无死亡。有效随访10例,随访12个月,累积一期通畅率为85.75%,均未行靶病变重建,2例发生截肢;术后12个月Rutherford分级及踝肱指数(ABI)均较术前明显改善(P均<0.05)。结论DCB治疗股总动脉病变短期疗效好,安全性高。Objective To observe the clinical efficacy and safety of drug-coated balloon(DCB)for treating common femoral artery lesions.Methods Eleven patients of single common femoral artery lesions treated with DCB were retrospectively analyzed.Results Among 11 cases,there were 7 cases of common femoral artery occlusion and 4 cases of severe stenosis,including 9 cases of primary lesions and 2 cases of in-stent restenosis,common femoral artery alone in 6 cases,and common femoral artery disease involved superficial femoral artery in 5 cases.The technical success rate was 100%.No treatment-related complication was observed.No death occurred within 30 days after operation.Ten patients were followed up,and 12-month primary patency rate was 85.75%.No target lesion reconstruction was performed,while 2 patients underwent major amputation.Rutherford categories and ankle brachial index(ABI)values were significantly improved on 12-month follow-up compared with those before operation(both P<0.05).Conclusion DCB has good short-term efficacy and high safety for treatment of common femoral artery lesions.

关 键 词：股动脉 外周血管疾病 血管成型术 球囊 

分 类 号：R543.5[医药卫生—心血管疾病] R815[医药卫生—内科学]